Atlas FDA

CARDIOSEAL SEPTAL OCCLUSION SYSTEM WITH QWIKLOAD

FDA premarket approval P000049/S012 · decided 2004-05-10

Approval details

PMA number
P000049
Supplement
S012
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
CARDIOSEAL SEPTAL OCCLUSION SYSTEM WITH QWIKLOAD
Generic name
Transcatheter septal occluder
Applicant
Nmt Medical, Inc.
Date received
2004-04-02
Decision date
2004-05-10
Days to decision
38 days
Decision code
APPR
Product code
MLV
Advisory committee
Cardiovascular
Expedited review
No
Location
Boston, MA
Statement
APPROVAL FOR THE ADDITION OF A WARNING TO THE LABELING THAT PROTAMINE SULFATE SHOULD NOT BE USED FOR HEPARIN REVERSAL BECAUSE OF THE POTENTIAL FOR THROMBUS FORMATION.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NMT MEDICAL TRANSSEPTAL SHEATH SET, MODELS TSS-10-HSC, TSS-11-HSC, TSS12-HSC (K034025)Nmt Medical, Inc.2004-03-26
SPETZLER ROUND HANDLE APPLIERS, MODELS C-3753, C-3753T, C-3754, C-3754T (K994191)Nmt Medical, Inc.2000-02-08